To the editor

JAMA - Journal of the American Medical Association

Volumn 312, Issue 20, 2014, Pages 2166-2167

  Blumenthal, James A ^a   Murali Doraiswamy, P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO; SERTRALINE;

CONTROLLED CLINICAL TRIAL (TOPIC); DATA ANALYSIS; DEPRESSION; EFFECT SIZE; EXERCISE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERMETHOD COMPARISON; LETTER; MEDICAL RESEARCH; META ANALYSIS (TOPIC); PATIENT ATTITUDE; PATIENT PARTICIPATION; PSYCHOTHERAPY; RATING SCALE; RELAPSE; REMISSION; RESEARCH SUBJECT; RISK REDUCTION; TREATMENT OUTCOME; UNITED STATES; VALIDITY; PSYCHOLOGY;

DEPRESSION; EXERCISE; HUMANS;

EID: 84914103882     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.14334     Document Type: Letter

References (5)

1. Cooney G, Dwan K, Mead G. Exercise for depression. JAMA. 2014;311(23): 2432-2433.
2. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-260.
3. Blumenthal JA, BabyakMA, Moore KA, et al. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999;159(19):2349-2356.
4. BabyakM, Blumenthal JA, Herman S, et al. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med. 2000;62(5):633-638.
5. Blumenthal JA, BabyakMA, Doraiswamy PM, et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med. 2007;69(7):587-596.